SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

SEGMENT INFORMATION

NOTE 9. SEGMENT INFORMATION

Our results of operations for the nine months ended September 30, 2025 and 2024 represent a single operating and reporting segment referred to as Contract Manufacturing within the EMS industry. The Company operates in the Medical Device, Medical Imaging, Aerospace and Defense, and Industrial markets with over 50% of its net sales coming from the medical-related markets. We strategically direct production between our various manufacturing facilities based on several considerations to best meet our customers’ needs. Our plants generate net sales over several of the markets the Company serves. We share resources for sales, marketing, engineering, supply chain, information services, human resources, payroll, and all corporate accounting functions. Our chief operating decision maker (the “CODM”) is the Company’s President and Chief Executive Officer. The CODM regularly evaluates financial information prepared in accordance with U.S. GAAP on a consolidated basis to assess performance and allocate resources.

The Company’s net sales were located as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
United States	$	18,170	$	20,704	$	52,485	$	66,713
Mexico		7,079		7,207		21,554		21,564
China		5,233		3,496		14,013		11,236
Total net sales	$	30,482	$	31,407	$	88,052	$	99,513

The Company’s long-lived tangible assets, including the Company’s operating lease assets recognized on the condensed consolidated balance sheets were located as follows:

	September 30, 2025		December 31, 2024
United States	$	9,568	$	10,429
Mexico		2,087		2,445
China		973		1,497
Total long-lived tangible assets	$	12,628	$	14,371